Call Us: 1.800.873.5297

By

Roger C. Denton, Founding Partner of Schlichter, Bogard & Denton, LLP, Selected as a 2013 Super Lawyer®

Roger DentonSchlichter, Bogard & Denton, LLP is proud to announce that Roger C. Denton has been selected as a 2013 Super Lawyer®, which is a distinction given to attorneys who have attained a high-degree of peer recognition and professional achievement. The selection process involves independent research by Thomson Reuters, along with consideration of peer nominations and evaluations.

Roger C. Denton is a founding partner and the chair of the Pharmaceutical Litigation Department at Schlichter, Bogard & Denton, LLP. Mr. Denton has devoted his legal career to representing individuals who have been seriously injured. Mr. Denton has extensive experience litigating pharmaceutical products liability cases involving defective drugs and devices, representing thousands of clients. Mr. Denton has obtained numerous multi-million dollar verdicts and settlements against Fortune 500 companies and other corporations, building his reputation as an aggressive litigator and trial attorney.

Mr. Denton graduated in 1978, cum laude, with a Bachelor of Arts Degree from Culver-Stockton College in Missouri. He attended law school at St. Louis University School of Law, where he was a member of the Law Journal, and obtained his Juris Doctor in 1982, graduating summa cum laude. He was admitted to practice law in 1982 in Illinois, in 1983 in Missouri, and in 1998 in Wisconsin. He is also admitted to practice before the United Supreme Court, the United States Courts of Appeals for the Seventh and Eighth Circuits, and the United States District Courts in Illinois, Indiana, Missouri, and Wisconsin. Mr. Denton’s “AV” rating in Martindale-Hubbell is the highest level available and represents the judgment of his peers about his professionalism, quality and expertise in legal work, and ethics.  Mr. Denton is an Executive Board Member of the Mass Tort Trial Lawyer Association, a member of the American Association for Justice, a member of the Illinois Trial Lawyers Association and a member of Missouri Association of Trial Attorneys. He is also a frequent speaker at national and local seminars and conferences involving mass torts and pharmaceutical litigation.

Mr. Denton has a national reputation as a leader in pharmaceutical litigation. He is acting as MDL Liaison Counsel in the Multidistrict Litigation In re Yasmin® and Yaz® (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL 2100), having been appointed by Chief Judge David Herndon of the Southern District of Illinois. Mr. Denton is Co-Lead Counsel in the Multidistrict Litigation In re: NuvaRing® Products Liability Litigation (MDL 1964), having been appointed by Judge Rodney Sippel of the Eastern District of Missouri; the Multidistrict Litigation In Re: E.I. Du Pont De Nemours and Company C-8 Personal Injury Litigation (MDL 2433), having been appointed by Judge Edmund Sargus of the Southern District of Ohio; and the Multidistrict Litigation In re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation (MDL 2385), having been appointed by Chief Judge Herndon of the Southern District of Illinois. Mr. Denton has also served on the National Plaintiffs’ Steering Committees in the Multidistrict Litigation In re Ortho Evra® Products Liability Litigation (MDL 1742), appointed by Judge David A. Katz of the Northern District of Ohio, as well as the Multidistrict Litigation In re Gadolinium-Based Contrast Agents Product Liability Litigation (MDL 1909), appointed by Judge Dan A. Polster of the Northern District of Ohio. Mr. Denton is also active in the HRT Litigation pending in the City of St. Louis, Missouri Circuit Court, where he is representing women throughout the country who have breast cancer caused by hormone replacement drugs.

As a founding partner of Schlichter, Bogard & Denton, LLP, Mr. Denton represents clients throughout the United States. Schlichter, Bogard & Denton, LLP has a national reputation for being a leader in complex litigation matters, including dangerous pharmaceutical and unsafe medical device cases. Our highest priority at Schlichter, Bogard & Denton, LLP is our commitment to practicing law to the highest standard of excellence in every phase of the trial process.

 

Legal Disclaimer: The choice of a lawyer is an important decision and should not be based solely on advertisements.

000-017   000-080   000-089   000-104   000-105   000-106   070-461   100-101   100-105  , 100-105  , 101   101-400   102-400   1V0-601   1Y0-201   1Z0-051   1Z0-060   1Z0-061   1Z0-144   1z0-434   1Z0-803   1Z0-804   1z0-808   200-101   200-120   200-125  , 200-125  , 200-310   200-355   210-060   210-065   210-260   220-801   220-802   220-901   220-902   2V0-620   2V0-621   2V0-621D   300-070   300-075   300-101   300-115   300-135   3002   300-206   300-208   300-209   300-320   350-001   350-018   350-029   350-030   350-050   350-060   350-080   352-001   400-051   400-101   400-201   500-260   640-692   640-911   640-916   642-732   642-999   700-501   70-177   70-178   70-243   70-246   70-270   70-346   70-347   70-410   70-411   70-412   70-413   70-417   70-461   70-462   70-463   70-480   70-483   70-486   70-487   70-488   70-532   70-533   70-534   70-980   74-678   810-403   9A0-385   9L0-012   9L0-066   ADM-201   AWS-SYSOPS   C_TFIN52_66   c2010-652   c2010-657   CAP   CAS-002   CCA-500   CISM   CISSP   CRISC   EX200   EX300   HP0-S42   ICBB   ICGB   ITILFND   JK0-022   JN0-102   JN0-360   LX0-103   LX0-104   M70-101   MB2-704   MB2-707   MB5-705   MB6-703   N10-006   NS0-157   NSE4   OG0-091   OG0-093   PEGACPBA71V1   PMP   PR000041   SSCP   SY0-401   VCP550  

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.